Seroprevalence of antibody to S1 spike protein following vaccination against COVID-19 in patients receiving hemodialysis: a call to arms
- 19 April 2021
- journal article
- letter
- Published by Elsevier BV in Kidney International
- Vol. 99 (6), 1492-1494
- https://doi.org/10.1016/j.kint.2021.04.008
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant RecipientsJAMA, 2021
- Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccineThe Lancet, 2021
- Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trialsThe Lancet, 2021
- Systematic Review of Safety and Efficacy of COVID-19 Vaccines in Patients With Kidney DiseaseKidney International Reports, 2021
- Factors associated with COVID-19-related death using OpenSAFELYNature, 2020